Skip to main content

Human iPSC-Derived Brown Fat Preadipocytes: i-HBrPAd

Human iPSC-Derived Brown Fat Preadipocytes (i-HBrPAd) are specialized adipocyte precursor cells generated through the directed differentiation of human induced pluripotent stem cells (iPSCs).

Quantity

Description

Human iPSC-Derived Brown Fat Preadipocytes (i-HBrPAd) are specialized adipocyte precursor cells generated through the directed differentiation of human induced pluripotent stem cells (iPSCs). Unlike continuous cell lines or transformed immortalized brown adipocyte models such as PAZ6 cells, i-HBrPAd represent a non-transformed, stable intermediate progenitor cell type cryopreserved at the precursor stage before full maturation. Characterized as committed brown adipocyte (BA) progenitors rather than uncommitted mesenchymal stem cells, these cells display consistent rates of controlled cell proliferation in vitro when maintained in specialized growth media. Comprehensive quality control utilizing mRNA expression profiling, single-cell RNA sequencing, and immunofluorescence analysis verifies that these high-purity preadipocytes display strong baseline positivity for the transcription factor PRDM16 (PR domain containing 16) — a key marker and master regulator indicating they are strongly directed toward a thermogenic fate before triggering downstream adipocyte differentiation.

While i-HBrPAd themselves are engineered in vitro from human pluripotent stem cells, their native primary cell counterparts — human preadipocytes committed to a thermogenic lineage — reside within specific specialized adipose tissue depots. Historically, the biological evaluation of human brown adipose tissue (BAT) has been severely constrained because classical brown adipocytes are exceptionally scarce and diffusely distributed in adult humans. In human newborns, classical brown adipocytes are highly concentrated in the interscapular BAT region to protect against cold-induced stress, but this classical depot regresses over time. In adult humans, functional thermogenic fat is scattered within white adipose tissue (WAT) depots, particularly in the supraclavicular and deep cervical regions. These cells are frequently referred to as beige adipocytes or brite adipocytes (brown-in-white) and often arise via inducible programs, whereas classical brown fat cells typically share a developmental origin with skeletal muscle — deriving from Myf5+ paraxial mesoderm precursors as shown in mouse models. Because primary human brown adipocytes are exceptionally difficult to biopsy from deep tissue layers without contaminating the sample with surrounding white adipocyte fractions, epithelial or endothelial cells, i-HBrPAd provide a clean, accessible alternative to study human-specific tissue.

The primary biological function of i-HBrPAd is to expand cleanly in culture and, upon receiving specific adipogenic triggers, consistently undergo morphological maturation into highly functional, differentiated adipocytes. When cultured in an optimized cell culture media setup — such as a specialized Preadipocyte Differentiation and Maturation Medium—the cells typically mature within 14 days into multilocular adipocytes filled with a dense arrangement of small intracellular lipid vesicles, which can be visualized via Oil Red O staining. Functionally mature brown adipocytes are uniquely specialized for non-shivering thermogenesis, a defining process driven by uncoupling protein 1 (UCP1), a proton channel localized to the inner mitochondrial membrane. Upon activation (commonly simulated in vitro via -adrenergic receptor agonists or cold-induction signaling pathway factors), UCP1 uncouples mitochondrial oxidative phosphorylation from ATP synthesis, dissipating energy directly as heat. To fuel this high-rate mitochondrial oxidation, these cells act as metabolic sinks, displaying increased glucose and fatty acid uptake and acting as an endocrine organ that secretes specialized signaling peptides and lipids termed batokines (such as FGF21 and IL-6) to modulate systemic insulin sensitivity.

In laboratory settings, i-HBrPAd provide a robust, scalable human platform for molecular biology, tissue engineering, and translational drug discovery. Researchers utilize these cells to evaluate shifts in gene expression and map out the up- or down-regulation of classical adipocyte markers during cellular maturation. Because rodent adipose tissues differ substantially from human depots, human primary cells or iPSC-derived models are vital for clinical translation. Investigators deploy i-HBrPAd in high-throughput metabolic screenings to identify novel small molecules, biologics, or dietary compounds capable of activating human UCP1 expression or expanding functional BAT. Furthermore, because they are derived from human pluripotent stem cells, researchers can utilize specific patient-derived iPS cells to generate brown adipocytes carrying precise genetic variants associated with obesity, severe insulin resistance, or type 2 diabetes. This allows for patient-specific disease modeling to investigate how distinct genetic backgrounds influence human brown fat development, mitochondrial respiratory capacity, and potential therapeutic interventions for a widespread metabolic disorder.

For the first time, Cell Applications, Inc. makes Human Brown Fat Preadipocytes (i-HBrPAd) available for research. Until now, studying human brown fat was nearly impossible due to its extreme scarcity in adults. But with our exclusive i-HBrPAd, derived from pluripotent stem cells and cryopreserved before maturation, researchers finally have direct access to this critical brown adipose tissue.

Using our Preadipocyte Differentiation and Maturation Medium, i-HBrPAd cells fully mature in just 14 days and remain healthy and responsive for up to two weeks post-differentiation. These fat cells are over 97% positive for PRDM16, the essential thermogenic factor in brown fat development, and show the multilocular adipose vesicles unique to brown fat upon Oil Red O staining.

With Cell Applications’ Brown Fat, researchers can now explore new frontiers in obesity, weight management and diabetes treatments and gain insights into brown fat development and its potential for in vivo generation. This world-first innovation changes what’s possible in metabolic research.

Details

Source Derived from Human iPSC of a single donor.
QC No bacteria, yeast, fungi, mycoplasma, virus.
Bioassay Positive for PRDM16 staining.
Cryovial Set of three cryovials (each yielding approximately 100,000 attached, viable cells), for ~300,000 total equivalent of i-HBrPAd (first passage), in freezing medium. Three million total cells are included in Cat# i804-30 and i804K-30, and approximately 10% (300,000) viable cells attach.
Kit Cryovial frozen i-HBrPAd cells (i804-30), i-HBrPAd Thawing Medium (i8117T-30), i-HBrPAd Differentiation Medium Kit (i8117DK-15), i-HBrPAd Expansion Medium Kit (i8117EK-10),  i-HBrPAd Maturation Medium Kit (i8117MK-50), HiPSC Xeno-Free Coating Solution Stock (126XF-005).
Cultured Contact us for availability.
Doublings The cells are non-proliferative.
Applications Laboratory research use only (RUO). Not for human, clinical, diagnostic or veterinary use.
Instructions i-HBrPAd

Format: PDF

DOWNLOAD NOW

Resources

5 Important Cell Culture Rules

Format: PDF

DOWNLOAD NOW

FAQs